Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

12/10/2018 07:00

Oct 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2018        Aug 31, 2017     May 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            153.53              138.73           610.00    
                 (+10.7 pct)         (+9.6 pct)       (+9.3 pct)  
  Operating          7.00                6.26            23.00    
                 (+11.8 pct)         (-8.0 pct)       (+1.1 pct)  
  Recurring          7.55                6.86            25.50    
                 (+10.2 pct)         (-5.9 pct)       (+1.0 pct)  
  Net                4.89                4.64            17.65    
                 (+5.3 pct)          (+0.5 pct)       (+0.1 pct)  
  EPS            246.73 yen          234.29 yen       891.43 yen  
  Ann Div                             90.00 yen        90.00 yen  
  -Q2 div                             45.00 yen        45.00 yen  
  -Q4 div                             45.00 yen        45.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T